Serum IL-6: A biomarker in childhood asthma?
- PMID: 32004524
- PMCID: PMC7282967
- DOI: 10.1016/j.jaci.2020.01.021
Serum IL-6: A biomarker in childhood asthma?
Abstract
Serum IL-6 was associated with asthma exacerbation risk but not with symptoms or lung function in urban children; further studies to evaluate the role of IL-6 in the life course of asthma are needed.
Figures
References
-
- Jevnikar Z, Ostling J, Ax E, Calven J, Thorn K, Israelsson E, et al. Epithelial IL-6 trans-signaling defines a new asthma phenotype with increased airway inflammation. J Allergy Clin Immunol. 2018. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- UL1 TR000154/TR/NCATS NIH HHS/United States
- UL1 TR000150/TR/NCATS NIH HHS/United States
- UM2 AI117870/AI/NIAID NIH HHS/United States
- UL1 RR025780/RR/NCRR NIH HHS/United States
- UL1 TR001422/TR/NCATS NIH HHS/United States
- UM1 AI114271/AI/NIAID NIH HHS/United States
- UL1 TR000075/TR/NCATS NIH HHS/United States
- UL1 TR000040/TR/NCATS NIH HHS/United States
- UL1 TR001105/TR/NCATS NIH HHS/United States
- UL1 TR001082/TR/NCATS NIH HHS/United States
- UL1 TR000077/TR/NCATS NIH HHS/United States
- UL1 TR000451/TR/NCATS NIH HHS/United States